View 5 related solutions for
Clone System Access
The diagram above shows the systems that can be accessed via the Clone, for descriptions and a list of roles per system click here. If you need access to other systems, please find below our guidelines:
- RAMOS – Contact GSK
- Express – Contact GSK
- Intralinks – Contact Novartis
To access the Clone Systems, you need to complete the mandatory training (where applicable) and then request system access, see below for more information.
For non-PAREXEL employees:
- You need to contact your PAREXEL Virtual Line Manager (list below) who will ensure you are assigned the relevant training (where required) and will raise a request on your behalf.
- Prior to contacting your PAREXEL Virtual Line Manager you should review the list of Systems and roles to determine your specific access requirements.
- For PAREXEL employees
PLEASE NOTE: As a result of a required change in the location of “NVS-ONC-MDL” prefixed files, which includes all trainings on the Novartis Oncology partnership training curriculum, these trainings have been hidden from the LMS search function for Learners and Line Managers (LM).
If a learner needs to complete one of these courses that is not part of their primary role assignment, the LM should log a help desk ticket with NVSOncology@PAREXEL.com. The Help Desk will forward the request to the L2-LMS App Support team who can manually assign the course to the user’s LMS course roster so that it will appear on their LMS ToDo list.
Phase II-III Services
Randomization and Trial Supply Management
PAREXEL® Informatics provides automated randomization and supplies management through its ClinPhone® RTSM (Randomization and Trial Supply Management) solution. Our services are offered by the industry's most experience and trusted provider of IVR (Interactive Voice Response) and IWR (Interactive Web Response) technologies.
Electronic Clinical Outcome Assessments (eCOA)
Clinical Outcome Assessments (COAs) measure a patient’s symptoms, overall mental state, or the effects of a disease or condition on how the patient functions. COAs can be used to determine whether or not a drug has been demonstrated to provide treatment benefit. COA types include ePRO (electronic Patient Reported Outcomes).